VBI Vaccines Inc., a biotechnology company, engages in the formulation, development, and delivery of vaccines. It develops Thermostable IM flu vaccine for the needs of pediatric, adult, and geriatric markets; Thermostable IM measles vaccines; Thermostable Oral flu and Shigella vaccines; prophylactic VLP-based vaccines to prevent cytomegalovirus infections and diseases; and seasonal/pandemic influenza vaccines. The company serves customers in the United States and internationally. VBI Vaccines Inc. was formerly known as Variation Biotechnologies (US), Inc. The company was founded in 2001 and is based in Cambridge, Massachusetts with research facilities in Ottawa, Canada.